Language selection

Government of Canada / Gouvernement du Canada

Search

Patent restoration and the cost of pharmaceuticals .: YN5-156/2018E-PDF

"This report estimates additional drug costs to Canadian consumers from changes to the Patent Law as negotiated under the Canada-European Union Comprehensive Economic and Trade Agreement (CETA). A two-year certificate of supplementary protection (CSP; elsewhere termed patent restoration, and used synonymously here since CSP provides patent-like protection) will delay the introduction of generic alternatives, and likely keep prices higher than they otherwise would be. The report also estimates the fiscal cost to the federal government of compensating provinces for increased costs to provincial public drug programs”--Verso of cover.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.856574&sl=0

Publication information
Department/Agency
  • Canada. Office of the Parliamentary Budget Officer.
TitlePatent restoration and the cost of pharmaceuticals .
Publication typeMonograph
Language[English]
Other language editions[French]
FormatDigital text
Electronic document
Note(s)
  • Issued also in French under title: La prolongation de la durée des brevets et le coût des médicaments.
  • Cover title.
  • "26 April 2018."
  • Includes bibliographical references.
Publishing information
  • Ottawa : Office of the Parliamentary Budget Officer, 2018.
Description41 p. : col. charts
Catalogue number
  • YN5-156/2018E-PDF
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: